1. Home
  2. IAUX vs ATAI Comparison

IAUX vs ATAI Comparison

Compare IAUX & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IAUX
  • ATAI
  • Stock Information
  • Founded
  • IAUX 2020
  • ATAI 2018
  • Country
  • IAUX United States
  • ATAI Germany
  • Employees
  • IAUX N/A
  • ATAI N/A
  • Industry
  • IAUX
  • ATAI Biotechnology: Pharmaceutical Preparations
  • Sector
  • IAUX
  • ATAI Health Care
  • Exchange
  • IAUX Nasdaq
  • ATAI Nasdaq
  • Market Cap
  • IAUX 261.9M
  • ATAI 214.8M
  • IPO Year
  • IAUX N/A
  • ATAI 2021
  • Fundamental
  • Price
  • IAUX $0.51
  • ATAI $1.24
  • Analyst Decision
  • IAUX
  • ATAI Strong Buy
  • Analyst Count
  • IAUX 0
  • ATAI 4
  • Target Price
  • IAUX N/A
  • ATAI $9.00
  • AVG Volume (30 Days)
  • IAUX 7.2M
  • ATAI 1.3M
  • Earning Date
  • IAUX 11-12-2024
  • ATAI 11-13-2024
  • Dividend Yield
  • IAUX N/A
  • ATAI N/A
  • EPS Growth
  • IAUX N/A
  • ATAI N/A
  • EPS
  • IAUX N/A
  • ATAI N/A
  • Revenue
  • IAUX $52,944,000.00
  • ATAI $331,000.00
  • Revenue This Year
  • IAUX N/A
  • ATAI $93.15
  • Revenue Next Year
  • IAUX $158.96
  • ATAI N/A
  • P/E Ratio
  • IAUX N/A
  • ATAI N/A
  • Revenue Growth
  • IAUX 30.02
  • ATAI N/A
  • 52 Week Low
  • IAUX $0.34
  • ATAI $1.03
  • 52 Week High
  • IAUX $1.88
  • ATAI $2.85
  • Technical
  • Relative Strength Index (RSI)
  • IAUX 34.03
  • ATAI 33.95
  • Support Level
  • IAUX $0.48
  • ATAI $1.15
  • Resistance Level
  • IAUX $0.66
  • ATAI $1.69
  • Average True Range (ATR)
  • IAUX 0.04
  • ATAI 0.11
  • MACD
  • IAUX 0.00
  • ATAI -0.06
  • Stochastic Oscillator
  • IAUX 6.42
  • ATAI 3.69

About IAUX i-80 Gold Corp.

i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

Share on Social Networks: